Team:Brasil-SP
From 2014.igem.org
Line 78: | Line 78: | ||
<tr><td bgColor="#e7e7e7" colspan="3" height="1px"> </tr> | <tr><td bgColor="#e7e7e7" colspan="3" height="1px"> </tr> | ||
<tr> <td colspan="3" height="5px"> </td></tr> | <tr> <td colspan="3" height="5px"> </td></tr> | ||
+ | |||
<tr> | <tr> | ||
- | <td colspan="3"><h3 align="center">Pre Structure</h3> | + | <td colspan="3"><h3 align="center">Project Description</h3> |
+ | <p>Our project consists of a biological molecular device (using Bacillus subtilis as chassis) for detection of Cystatin C, a biomarker of chronic kidney disease. The genetic circuit being assembled is based on the outstanding project of the Imperial College of London team of iGEM 2010 (special thanks to the ex-iGEMer Christopher Hirst, who helped us a lot sending some important BioBricks to us). Part of our mission is also to improve the characterization of the BioBricks developed on 2010 and to validate the molecular design as a generic detection system. This flexibility of detection is based on a protease cleavage of a membrane protein who triggers the genetic circuit. Since any cleavage site could be designed, virtually any protease could be used as a signal for the detection. In our case, the disease biomarker will inhibit the action of our chosed protease (Cathepsin S) and the detection will be made indirectlly and negativelly - <i>i.e.</i> by the Cathepsin lack of protease activity and absense of the system output. We're on the way to assemble all the parts and properlly characterize each part of our construction on time for the Jamboree.<br> To address a real world situation, we are working on the same principle and aesthetics of the well know devices for biotecetion like pregnancy or HIV tests: ease-to-use microfluidic devices. The plan is to design a microchip able to store spores of the developed strains of B.subtilis and safely expose blood samples to our biodetection system, successfully containing the biomaterial and enabling a proper discard of the chip. <i>A priori</i>, the device output monitoring would require a fluorescence detector tool, but we also propose a naked eye output observation as a concept for future prospects.<br> Because we're woking a solution directlly associated with a ordinary user, the concern about the perception of public opinion about synthetic biology is very important not only to know about the social impact of our work, but to help evaluate the biosafety and bioethical issues beyond a simple risk analysis - a sociological analysis of the values of our project. So, as a policy and practices approach, we'll try to draw a picture of the public opinion of Brazil on these issues using a questionary to evaluate our actual scenario and, in a certain way, our own project.</p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | |||
+ | <tr> | ||
+ | <td colspan="3"><h3 align="center">Wiki Pre Structure (Under Construction!)</h3> | ||
<p>This is the initial wiki pre structure that might be changed over its development. <b>Everything here is merely provisional!</b></p> | <p>This is the initial wiki pre structure that might be changed over its development. <b>Everything here is merely provisional!</b></p> | ||
<p align="left"> | <p align="left"> |
Revision as of 03:18, 14 August 2014
WELCOME TO iGEM 2014!Your team has been approved and you are ready to start the iGEM season!
|
||||||||||||
| ||||||||||||
Project DescriptionOur project consists of a biological molecular device (using Bacillus subtilis as chassis) for detection of Cystatin C, a biomarker of chronic kidney disease. The genetic circuit being assembled is based on the outstanding project of the Imperial College of London team of iGEM 2010 (special thanks to the ex-iGEMer Christopher Hirst, who helped us a lot sending some important BioBricks to us). Part of our mission is also to improve the characterization of the BioBricks developed on 2010 and to validate the molecular design as a generic detection system. This flexibility of detection is based on a protease cleavage of a membrane protein who triggers the genetic circuit. Since any cleavage site could be designed, virtually any protease could be used as a signal for the detection. In our case, the disease biomarker will inhibit the action of our chosed protease (Cathepsin S) and the detection will be made indirectlly and negativelly - i.e. by the Cathepsin lack of protease activity and absense of the system output. We're on the way to assemble all the parts and properlly characterize each part of our construction on time for the Jamboree. |
||||||||||||
Wiki Pre Structure (Under Construction!)This is the initial wiki pre structure that might be changed over its development. Everything here is merely provisional!
|
||||||||||||
Requirements | ||||||||||||
Please be sure to keep these links, your audience will want to find your: |
There are a few wiki requirements teams must follow:
Visit the Wiki How To page for a complete list of requirements, tips and other useful information. |
|||||||||||
Tips | ||||||||||||
We are currently working on providing teams with some easy to use design templates.
For a full wiki list, you can visit iGEM 2013 web sites and iGEM 2012 web sites lists. |
This wiki will be your team’s first interaction with the rest of the world, so here are a few tips to help you get started:
|